HealthcarePress Releases

Inhalation Anesthesia Market Size to Record USD 24 billion by 2030

Share This Article

global inhalation anesthesia market was evaluated at USD 15.5 billion in 2020 and is speculated to accrue USD 24 billion by 2030, growing at 5.5% CAGR between 2021-2030.

The inhalation anesthesia market report covers a detailed analysis for the historic period 2017-2020, considering 2021 as the base year and forecast (growth) for 2021-2030.

Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1247

This research report evaluates the inhalation anesthesia market on a global and regional level. It offers a thorough analysis of the market revenue status, growth, future trends, and forecast of the global inhalation anesthesia market for the period from 2017 to 2030.

Growth Factors

Growing numbers of surgical procedures across the globe, along with emergence of the trauma cases worldwide are some among the major factors driving growth of the global market. Additionally, increasing geriatric population, increasing cancer patient pool, rising cardiovascular, gastrointestinal, respiratory, neurological disorders are expected to propel growth of the target market in next 10 years.

The North American region is expected to dominate in the global inhalation anesthesia market over the forecast period. The growth is attributed to increasing chronic diseases and availability for advanced healthcare facility in the U.S. Additionally, increasing number of surgical procedures along with early acceptance of advanced technology in the region are expected to fuel growth of the target market over the forecast period.

However, factors such as side effects of inhalation anesthetics as well as lack of awareness may restrict the inhalation anesthesia market globally. Nevertheless, untapped markets can create lucrative growth opportunity for the key players in the global market. Key players are using innovative technology to deliver high-quality goods that meet the changing needs of the end-user industries which is anticipated to propel growth of the global market in the near future.

Market Report Scope

Report Highlights Details
Market Size USD 24 Billion by 2030
Growth Rate CAGR of 5.5% From 2021 to 2030
Base Year 2020
Historic Data 2017 to 2020
Forecast Period 2021 to 2030
Segmentes Covered Product, Application, End use
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)

For More Information or Customization Before Buying, Visit @ https://www.precedenceresearch.com/customization/1247

This report enables readers to make important decisions with regard to their business, with the help of a wealth of Information enclosed in the study. The report also provides the compound annual growth rate (CAGR) of the global inhalation anesthesia market for the forecast period of 2021–2030. This data can help readers interpret quantitative growth aspects of the global market during the forecast period. It presents a wealth of information on key market dynamics, including drivers, market trends, and challenges, as well as the structure of the global market across the globe.

The report analyzes the historical and present-day scenario of the global inhalation anesthesia market to accurately gauge its growth potential. The study presents detailed information about important growth factors, restraints, and key trends that are creating the landscape for growth of the global market in order to identify opportunities for stakeholders.

Key Highlights

  • On the basis of anesthetics, product type segment will register supreme share in the near future. The anesthetics segment accounted for the maximum share of around 42% in year 2020 in terms of revenue. Apparatus segment will be increasing at substantial pace and will fuel growth of the inhalation anesthesia industry in the near future.
  • Based on application the global market is categorized as human healthcare and veterinary healthcare among which the services segment will register maximum share in the near future. Human healthcare segment is anticipated to register highest growth rate as well as market share over the forecast period of time.
  • Among the end user hospitals estimated as a dominant segment, along with maximum share in year 2020. The growth is attributed to growing adoption in the hospitals across the globe. Along with this the clinics segment is anticipated to grow at the noteworthy growth rate and will augment the market revenue.
  • Kent Scientific Corporation accounted for a significant share of the global inhalation anesthesia market due to the implementations of its innovative business strategies. Key strategies applied by the company will offers tremendous growth prospects for the vendors worldwide.
  • The report study offers global industry projections of inhalation anesthesia products round various regions like Asia-Pacific, Latin America, Europe, North America, and Middle East and Africa.
  • The North Americawill lead the worldwide industry owing togrowing prevalence of numerous chronic diseases, presence of advanced healthcare facilities, coupled with presence of major companies in the North American countries.
  • The Asia Pacific market is probable to list the striking CAGR, on account of growing demand for the inhalation anesthesiain emerging economies. Likewise, utmost of the companies functioning in the market are advancing deeply in order to get the modest advantage in the inhalation anesthesia market in the Asia Pacific.
  • The market in the Europe is expected to hold significant market share and the growth is attributed to the increased prevalence of respiratory diseases in the France, Russia, and U.K. of the region.

Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1247

Competition Landscape

In the final section of the research report, Precedence Research provided the global inhalation anesthesia market structure and a detailed competition landscape to provide a dashboard view of key players operating in the global market along with their business strategies to report audiences. This section is primarily designed to provide clients with an objective and detailed comparative assessment of the key providers specific to a market segment in the value chain of the market.

Some of the major players in the inhalation anesthesia market include:

  • Piramal Critical Care
  • Baxter
  • Midmark Corporation
  • Halocarbon
  • Hengrui Medicine
  • Kent Scientific Corporation
  • Merck KGaA
  • BOC
  • AbbVie Inc.
  • Raman & Weil Pvt. Ltd.

Market Segmentation

By Product Type

  • Apparatus
    • Isoflurane
    • Sevoflurane
    • Desflurane
    • Others
  • Anesthetics
  • Accessories

By Application

  • Human Healthcare
  • Veterinary Healthcare

By End user

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centres
  • Others

Regional Segmentation

– North America (U.S. and Canada)

 – Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)

 – Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)

 – Latin America (Brazil and Rest of Latin America)

– Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

  • Market estimate for 2020
  • Average selling price (ASP) per region for specific product type
  • Filtrations and assortment of gathered data, to estimate the base year (2021) market size for the country
  • Gathering data from company websites, annual reports, white papers, financial reports, broker reports, investor presentations, and SEC filings
  • National government documents, statistical databases
  • News articles, press releases, and webcasts specific to companies operating in the market
  • Country wise analysis through internal and external proprietary databases, and relevant patent and regulatory databases
  • Determination of market penetration by country

Most Asked Questions –

What was the market size value of the inhalation anesthesia in 2020?

What is the expected market size by 2030?

What is the inhalation anesthesia market growth?

What are the key factors that positively influence market growth?

Who are the prominent players in the inhalation anesthesia market?

Why Buy this Report?

The purpose of Precedence Research’s inhalation anesthesia market study is to provide stakeholders with a detailed picture of potential barriers and untapped opportunities. The report contains exclusive information to assist businesses in making informed decisions about how to maintain growth throughout the assessment period.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Inhalation Anesthesia Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Inhalation Anesthesia Market

5.1. Covid-19: Inhalation Anesthesia Industry Impact
5.2. Inhalation Anesthesia Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Inhalation Anesthesia Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Inhalation Anesthesia Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. Inhalation Anesthesia Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Surge in the prevalence of disorders such as respiratory diseases, gastrointestinal disorders, and cancer across the globe.
6.1.1.2. Increasing number of surgical procedures worldwide.
6.1.1.3. Growing geriatric population and growing number of emergency cases and accidents.
6.1.2. Market Restraints
6.1.2.1. Side effects associated with the inhalation anesthetics is major factor hampering target market growth
6.1.3. Market Opportunities
6.1.3.1. Emerging markets and ongoing research & development in the healthcare sector technologies

Chapter 7. Global Inhalation Anesthesia Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Inhalation Anesthesia Market Revenue by Market Players (2017 – 2020)
7.1.1.2. Inhalation Anesthesia Market Revenue Market Share by Market Players (2017 – 2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Process Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Inhalation Anesthesia Market, By Product Type

8.1. Inhalation Anesthesia Market, 2017-2030
8.2. Apparatus
8.2.1.1. Market Revenue Forecast (2017-2030)
8.3. Anesthetics
8.3.1.1. Market Revenue Forecast (2017-2030)
8.4. Accessories
8.4.1.1. Market Revenue Forecast (2017-2030)

Chapter 9. Global Inhalation Anesthesia Market, By Application

9.1. Inhalation Anesthesia Market, 2017-2030
9.2. Human Healthcare
9.2.1.1. Market Revenue Forecast (2017-2030)
9.3. Veterinary Healthcare
9.3.1.1. Market Revenue Forecast (2017-2030)

Chapter 10. Global Inhalation Anesthesia Market, By End User

10.1. Inhalation Anesthesia Market, 2017-2030
10.2. Hospitals
10.2.1.1. Market Revenue Forecast (2017-2030)
10.3. Clinics
10.3.1.1. Market Revenue Forecast (2017-2030)
10.4. Ambulatory Surgical Centers
10.4.1.1. Market Revenue Forecast (2017-2030)
10.5. Others
10.5.1.1. Market Revenue Forecast (2017-2030)

Chapter 11. Global Inhalation Anesthesia Market, Regional Estimates and Trend Forecast

11.1. North America
11.1.1. Market Revenue Forecast by Product Type(2017-2030)
11.1.2. Market Revenue Forecast by End-user(2017-2030)
11.1.3. Market Revenue Forecast by Organization Size(2017-2030)
11.1.4. U.S
11.1.4.1. Market Revenue Forecast (2017-2030)
11.1.5. Canada
11.1.5.1. Market Revenue Forecast (2017-2030)
11.2. Europe
11.2.1. Market Revenue Forecast by Product Type (2017-2030)
11.2.2. Market Revenue Forecast by End-user (2017-2030)
11.2.3. Market Revenue Forecast by Organization Size (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue Forecast (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue Forecast (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue Forecast (2017-2030)
11.2.7. Rest of EU
11.2.7.1. Market Revenue Forecast (2017-2030)
11.3. Asia Pacific (APAC)
11.3.1. Market Revenue Forecast by Product Type (2017-2030)
11.3.2. Market Revenue Forecast by End-user (2017-2030)
11.3.3. Market Revenue Forecast by Organization Size (2017-2030)
11.3.4. China
11.3.4.1. Market Revenue Forecast (2017-2030)
11.3.5. India
11.3.5.1. Market Revenue Forecast (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue Forecast (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue Forecast (2017-2030)
11.4. LATAM
11.4.1. Market Revenue Forecast by Product Type (2017-2030)
11.4.2. Market Revenue Forecast by End-user (2017-2030)
11.4.3. Market Revenue Forecast by Organization Size (2017-2030)
11.4.4. Brazil
11.4.4.1. Market Revenue Forecast (2017-2030)
11.4.5. Rest of LATAM
11.4.5.1. Market Revenue Forecast (2017-2030)
11.5. Middle East and Africa (MEA)
11.5.1. Market Revenue Forecast by Product Type (2017-2030)
11.5.2. Market Revenue Forecast by End-user (2017-2030)
11.5.3. Market Revenue Forecast by Organization Size (2017-2030)
11.5.4. GCC
11.5.4.1. Market Revenue Forecast (2017-2030)
11.5.5. North Africa
11.5.5.1. Market Revenue Forecast (2017-2030)
11.5.6. South Africa
11.5.6.1. Market Revenue Forecast (2017-2030)
11.5.7. Rest of MEA
11.5.7.1. Market Revenue Forecast (2017-2030)

Chapter 12. Company Profiles

12.1. AbbVie Inc.
12.1.1. Company Overview, Business Information, Regional Presence
12.1.2. Product Portfolio Analysis
12.1.2.1. Product Details, Specification, Product Type
12.1.3. Revenue, Price, and Gross Margin (2017-2020)
12.1.4. Recent Developments and Strategies
12.2. Baxter
12.2.1. Company Overview, Business Information, Regional Presence
12.2.2. Product Portfolio Analysis
12.2.2.1. Product Details, Specification, Product Type
12.2.3. Revenue, Price, and Gross Margin (2017-2020)
12.2.4. Recent Developments and Strategies
12.3. BOC
12.3.1. Company Overview, Business Information, Regional Presence
12.3.2. Product Portfolio Analysis
12.3.2.1. Product Details, Specification, Product Type
12.3.3. Revenue, Price, and Gross Margin (2017-2020)
12.3.4. Recent Developments and Strategies
12.4. Halocarbon
12.4.1. Company Overview, Business Information, Regional Presence
12.4.2. Product Portfolio Analysis
12.4.2.1. Product Details, Specification, Product Type
12.4.3. Revenue, Price, and Gross Margin (2017-2020)
12.4.4. Recent Developments and Strategies
12.5. Hengrui Medicine
12.5.1. Company Overview, Business Information, Regional Presence
12.5.2. Product Portfolio Analysis
12.5.2.1. Product Details, Specification, Product Type
12.5.3. Revenue, Price, and Gross Margin (2017-2020)
12.5.4. Recent Developments and Strategies
12.6. Kent Scientific Corporation
12.6.1. Company Overview, Business Information, Regional Presence
12.6.2. Product Portfolio Analysis
12.6.2.1. Product Details, Specification, Product Type
12.6.3. Revenue, Price, and Gross Margin (2017-2020)
12.6.4. Recent Developments and Strategies
12.7. Merck KGaA
12.7.1. Company Overview, Business Information, Regional Presence
12.7.2. Product Portfolio Analysis
12.7.2.1. Product Details, Specification, Product Type
12.7.3. Revenue, Price, and Gross Margin (2017-2020)
12.7.4. Recent Developments and Strategies
12.8. Midmark Corporation
12.8.1. Company Overview, Business Information, Regional Presence
12.8.2. Product Portfolio Analysis
12.8.2.1. Product Details, Specification, Product Type
12.8.3. Revenue, Price, and Gross Margin (2017-2020)
12.8.4. Recent Developments and Strategies
12.9. Piramal Critical Care
12.9.1. Company Overview, Business Information, Regional Presence
12.9.2. Product Portfolio Analysis
12.9.2.1. Product Details, Specification, Product Type
12.9.3. Revenue, Price, and Gross Margin (2017-2020)
12.9.4. Recent Developments and Strategies
12.10. Raman & Weil Pvt. Ltd.
12.10.1. Company Overview, Business Information, Regional Presence
12.10.2. Product Portfolio Analysis
12.10.2.1. Product Details, Specification, Product Type
12.10.3. Revenue, Price, and Gross Margin (2017-2020)
12.10.4. Recent Developments and Strategies

Chapter 13. Appendix

13.1. About Us
13.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1247

About Us

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

Contact Us:         

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

For Latest Update Follow Us:

https://www.linkedin.com/company/precedence-research/

https://www.facebook.com/precedenceresearch/

https://twitter.com/Precedence_R

Show More

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

Related Articles

Back to top button